Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:52 PM
Ignite Modification Date:
2025-12-24 @ 5:52 PM
NCT ID:
NCT03263468
Eligibility Criteria:
Inclusion Criteria:
* ST elevation myocardial infarction evidenced by new ST elevation at the J point in at least 2 contiguous leads of ≥ 2 mm (0.2mV) in men or ≥ 1.5mm (0.15mV) in women in leads V2-V3 and/or ≥ 1mm (0.1mV) in other contiguous chest leads or limb leads.
* MVD as evidenced by \> one significant (\>70% by visual assessment or FFR \< 0.80 for 50-70% stenosis) stenosis in the non-IRA \>2mm in diameter.
* Successful IRA-PCI with \<30% residual angiographic stenosis and TIMI III flow
* Written informed consent
Exclusion Criteria:
* Age ≤ 18 years
* Prior coronary artery bypass graft (CABG) surgery
* Administration of thrombolytic therapy.
* Hemodynamic instability as evidenced by SBP\<90 mmHg, Killip class ≥3, and/or need for inotropes/vasopressors.
* Known renal insufficiency (estimated GFR \< 30 ml/min/1.73m2)
* Non-IRA stenosis is a chronic total occlusion (CTO)
* Plan by treating physician to treat non-IRA stenosis with coronary artery bypass surgery
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03263468
Study Brief:
Protocol Section:
NCT03263468